Post Reply
221-239 of 239
This one is surprising strong @ $0.032 despite coming up from $0.018 last week
It looks like the price might soon reverse back to the 30 range.
tuntun ( Date: 24-Jul-2024 10:14) Posted:
|
In at 23 total 280 lots and sold all at 37 .. great profit again . Good luck those holding before SGX query ..
SLLIMJ ( Date: 24-Jul-2024 10:02) Posted:
|
in at 34 out at 41 earn small money. For those buying just becareful can go up or down anytime.
salted fish also will flip
10 cts otot
tankoksee ( Date: 24-Jul-2024 09:42) Posted:
|
can smell 50 ah?
easywin ( Date: 24-Jul-2024 09:29) Posted:
|
Buy for easy money just like TC Auto
finally in play
can only find this recent annoucenment 15jul, reason for the jump?
https://links.sgx.com/1.0.0/corporate-announcements/UJYVNG76Z23UPWZV/809705_Livingstone%20-%20Proposed%20Restructuring%20Ann.pdf
https://links.sgx.com/1.0.0/corporate-announcements/UJYVNG76Z23UPWZV/809705_Livingstone%20-%20Proposed%20Restructuring%20Ann.pdf
Yesterday IX Biopharma run today this? Hopefully not PnD like IX .
Wow volume picking up. $0.018 $0.002
Maybe tomorrow will play?
Maybe tomorrow will play?
SmallSmall ( Date: 10-Jul-2024 09:32) Posted:
|
Livingstone Health seeks to raise $1.5 mil through proposed placement
Livingstone Health has proposed to place 55.56 million shares at an issue price of 2.7 cents per share. The consideration from the placement will amount to some $1.5 million.
The proposed placement is not underwritten and will be undertaken by way of an exempt offering in Singapore in accordance with Section 272B of the Securities and Futures Act (SFA).
The issue price represents a discount of around 8.78% to the volume weighted average price (VWAP) of 2.96 cents for the shares traded on Feb 7.
The placement shares represent about 12.7% of the company&rsquo s existing share capital of 436.39 million shares. It will represent about 11.3% of the enlarged share base thereafter.
According to Livingstone, the proposed placement will strengthen its balance sheet in its bid to explore strategic acquisition plans and, or new business opportunities. The group is also pursuing organic growth and expanding its medical specialist teams through new recruitments to support the growing demand in healthcare services, it says.
On a pro forma basis, the group&rsquo s net tangible assets (NTA) per share would have been at 0.61 cents instead of 0.36 cents after the proposed placement should it have been completed on March 31, 2023.
The pro forma earnings per share (EPS), if the placement was completed on April 1, 2022, would&rsquo ve been 0.15 cents instead of 0.17 cents.
Anyone talks about this one?
Livingstone Health Holdings
On Aug 22, Livingstone Health Holdings : PRH 0% executive director and CEO Wilson Tay Ching Yit acquired 92,000 shares of the Catalist-listed company at an average price of 11.6 cents per share. With a consideration of S$10,672, this increased Dr Tay&rsquo s total interest in the multidisciplinary healthcare group from 58.53 per cent to 58.55 per cent.
Livingstone Health Holdings
Between Aug 15 and 16, Livingstone Health Holdings : PRH 0% executive director and CEO Wilson Tay Ching Yit acquired 200,000 shares of the Catalist-listed company at an average price of 11.9 cents per share.
With a consideration of S$23,800, this increased his total interest in the multidisciplinary healthcare group from 58.48 per cent to 58.53 per cent.
Dr Tay specialises in anesthesiology, has 16 years of clinical experience, and is responsible for the overall strategic direction and development of the group.
Livingstone Health Holdings
On May 31, Livingstone Health Holdings : PRH -5.37% executive director and CEO, Wilson Tay, acquired 160,100 shares of the company for a consideration of S$22,244.
At an average price of 13.9 cents per share, this increased his total interest in the multidisciplinary healthcare group from 58.43 per cent to 58.47 per cent.
Dr Tay specialises in anaesthesiology with 15 years of clinical experience, and he is responsible for the overall strategic direction and development of the group.
Livingstone Health FY2022 Revenue Rises 41% to S$34.1 Million Proposes Final Dividend of 0.12 Singapore Cent Per Share
https://links.sgx.com/1.0.0/corporate-announcements/ZOVPZE7OP4FZQSST/841c507a0c587d3f03699bd26c4376b1487dc344ccd340c187300466df6a62e5
https://links.sgx.com/1.0.0/corporate-announcements/ZOVPZE7OP4FZQSST/841c507a0c587d3f03699bd26c4376b1487dc344ccd340c187300466df6a62e5
Chan is a sophisticated investor. Value of his holding almost double after RTO. Before RTO the shares were just junk - 0.001. After RTO 0.225 plus minus. If his shares were offload gradually...millions dollars will be made even though his share base shrink cos of consol 500 to 1. Very smart investor. Wish can be like him.